Published in J Urol on April 01, 1998
Epidemiology of Testicular Cancer in Oklahoma and the United States. J Okla State Med Assoc (2016) 0.75
Advanced testicular cancer in a society of racial and socio-economic health disparity. BMJ Case Rep (2013) 0.75
Carcinoembryonic antigen in patients with different cancers. JAMA (1972) 2.56
Causes, presentation and survival of fifty-seven patients with necrotizing fasciitis of the male genitalia. Surg Gynecol Obstet (1990) 2.31
Oxidative DNA damage in prostate cancer patients consuming tomato sauce-based entrees as a whole-food intervention. J Natl Cancer Inst (2001) 1.47
Therapeutic drug monitoring of amikacin in preterm and term infants. Singapore Med J (2009) 1.44
The effect of estrogen on the incorporation of 3H-thymidine by PHA-stimulated human peripheral blood lymphocytes. J Immunol (1974) 1.21
Growth of the rat prostate gland is facilitated by the autonomic nervous system. Biol Reprod (1994) 1.19
Involvement of the genitourinary system in multiple primary malignant neoplasms: a review. J Clin Oncol (1983) 1.18
Drosophila Amphiphysin is implicated in protein localization and membrane morphogenesis but not in synaptic vesicle endocytosis. Development (2001) 1.16
Urethral diverticular carcinoma. Cancer (1992) 1.01
Prostate cancer patients' utilities for health states: how it looks depends on where you stand. Med Decis Making (1998) 0.99
Patterns of care for carcinoma of the prostate gland: results of a national survey of 1984 and 1990. J Am Coll Surg (1995) 0.98
Overflow urinary incontinence due to carbamazepine. J Urol (1985) 0.97
Evaluation of an implant that delivers leuprolide for 1 year for the palliative treatment of prostate cancer. Urology (2000) 0.95
The accuracy of the rectal examination in the diagnosis of prostate carcinoma. N Engl J Med (1980) 0.94
In vitro effects of dichloroacetate and CO2 on hypoxic HeLa cells. Anticancer Res (2009) 0.92
Comparison of goserelin and leuprolide in combined androgen blockade therapy. Urology (1998) 0.91
Single-agent therapy with bicalutamide: a comparison with medical or surgical castration in the treatment of advanced prostate carcinoma. Urology (1995) 0.90
Changes in radical prostatectomy and radiation therapy rates for African Americans and whites. J Natl Med Assoc (2000) 0.90
Enhanced expression of parathyroid hormone-related protein in prostate cancer as compared with benign prostatic hyperplasia. Hum Pathol (1996) 0.89
Benign fibrous ureteral polyps. Urology (1987) 0.89
Carcinoembryonic antigen in patients with tumors of the urogenital tract. Cancer (1972) 0.89
Ethanolamine sclerotherapy of a renal cyst. J Urol (1995) 0.89
Warfarin resistance and vitamin K. Ann Intern Med (1981) 0.87
An evaluation of prostate specific antigen in prostatic cancer. J Urol (1987) 0.87
Long-term complete remission in bladder carcinoma in situ with intravesical TICE bacillus Calmette Guerin. Overview analysis of six phase II clinical trials. Urology (1991) 0.87
Chart for preparation of dilutions of alpha-adrenergic agonists for intracavernous use in treatment of priapism. J Urol (1995) 0.86
Renal cell carcinoma: the size variable. J Surg Oncol (1993) 0.86
Prostate cancer: the stage disadvantage in the black male. J Natl Med Assoc (1991) 0.85
Bacillus calmette-guerin (BCG) adjuvant therapy in stage D prostate cancer. Urology (1982) 0.85
Multiple primary tumors in a 72-year-old woman. J Urol (1983) 0.85
Effect of piperacillin on tobramycin pharmacokinetics in patients with normal renal function. Antimicrob Agents Chemother (1983) 0.85
Immunosuppressive effects of antimacrophage serum and antithymocyte serum on mouse skin allografts. J Med (1972) 0.84
Lipofuscin granules in normal, benign and malignant human prostatic tissue. Urol Res (1973) 0.84
In vivo establishment of T98G human glioblastoma. Methods Find Exp Clin Pharmacol (1999) 0.84
Safety and efficacy of intravesical aminocaproic acid for bleeding after transurethral resection of prostate. Urology (1986) 0.84
A novel locus for autosomal recessive form of hypotrichosis maps to chromosome 3q26.33-q27.3. J Med Genet (2004) 0.83
Tropomyosin and troponin regulation of wild type and E93K mutant actin filaments from Drosophila flight muscle. Charge reversal on actin changes actin-tropomyosin from on to off state. J Biol Chem (1998) 0.82
A comparison of perspectives on prostate cancer: analysis of utility assessments of patients and physicians. Eur Urol (1997) 0.82
Humoral hypercalcemia due to squamous cell carcinoma of renal pelvis. Urology (1988) 0.82
An evaluation of the markers p53 and Ki-67 for their predictive value in prostate cancer. J Surg Oncol (1998) 0.82
Zoladex: a sustained-release, monthly luteinizing hormone-releasing hormone analogue for the treatment of advanced prostate cancer. J Clin Oncol (1987) 0.81
Prognostic value of cell surface antigens using immunoperoxidase methods in bladder carcinoma. Urology (1982) 0.81
Stage IV renal cell carcinoma. J Urol (1994) 0.81
Condyloma acuminatum in a 2 1/2-year-old girl. J Urol (1983) 0.81
The proliferative response of hela cells to 2-deoxy-D-glucose under hypoxic or anoxic conditions: an analogue for studying some properties of in vivo solid cancers. Anticancer Res (2007) 0.81
Evaluation of cytologic techniques for diagnosis of prostate cancer. Urology (1983) 0.81
Prostate cancer and the multiple primary malignant neoplasm syndrome. Prostate (1983) 0.81
Spouse ratings of quality of life in patients with metastatic prostate cancer of lower socioeconomic status: an assessment of feasibility, reliability, and validity. Urology (2001) 0.81
Effects of sex steroids on cell growth and C-myc oncogene expression in LN-CaP and DU-145 prostatic carcinoma cell lines. Int Urol Nephrol (1995) 0.81
Antisense oligonucleotide intralesional therapy for human PC-3 prostate tumors carried in athymic nude mice. J Surg Oncol (1996) 0.80
Lymphocele formation after extraperitoneal pelvic lymphadenectomy: possible predisposing factors. J Urol (1986) 0.80
Comparison of ciprofloxacin and beta-lactam antibiotics in the treatment of urinary tract infections and alteration of fecal flora. Am J Med (1987) 0.80
Carcinoembryonic antigen in the diagnosis of prostate carcinoma. Oncology (1974) 0.80
Bone scan as a stratification variable in advanced prostate cancer. Cancer (1991) 0.80
Current patterns of inflicted head injury in children. Pediatr Neurosurg (1999) 0.80
A multi-attribute model of prostate cancer patient's preferences for health states. Qual Life Res (1999) 0.79
Application of immunohistologic staining to develop a malignant index to aid in distinguishing benign from malignant prostatic tissue. Prostate (1989) 0.79
Ultrasonic imaging during renal surgery for calculi. J Belge Radiol (1986) 0.79
Massive scrotal and occult preputial metastases from carcinoma of the prostate. Br J Urol (1978) 0.79
Normoxic or hypoxic CD44/CD41 a₂ B₁ integrin-positive prostate PC3 cell side fractions and cancer stem cells. Med Oncol (2013) 0.79
Enhanced expression of bcl-2 following antisense oligonucleotide mediated growth factor deprivation. Med Oncol (1997) 0.79
Retinal artery changes correlated with other hypertensive parameters in a coronary heart disease case-history study. Br Heart J (1968) 0.79
An immunohistologic characterization of human prostatic atypical hyperplasia. Urol Res (1990) 0.79
Quality of life in low-income patients with metastatic prostate cancer: divergent and convergent validity of three instruments. Qual Life Res (1999) 0.79
Carcinoembryonic-like antigen in the urine of patients with carcinoma of the bladder and normal controls. J Surg Oncol (1974) 0.78
Comparison of EMIT versus bioassay to evaluate inactivation of tobramycin by piperacillin. Ther Drug Monit (1987) 0.78
Urinary carcinoembryonic-like antigen levels in patients with bladder carcinoma. J Urol (1974) 0.78
The effect of androgen deprivation on malignant and benign prostate tissue. Med Oncol (1998) 0.78
Differential expression of p53, c-kit, and CD34 in prepubertal and postpubertal testicular germ cell tumors. Cancer (1997) 0.78
The effect of normoxia and hypoxia on a prostate (PC-3) CD44/CD41 cell side fraction. Anticancer Res (2011) 0.78
Phase II trial of echinomycin in advanced hormone-resistant prostate cancer. An Illinois Cancer Council study. Invest New Drugs (1994) 0.78
Are cancer stem cells concentrated in more alkaline hypoxic regions of tumors? Med Hypotheses (2009) 0.78
Treatment of the T98G glioblastoma cell line with antisense oligonucleotides directed toward mRNA encoding transforming growth factor-alpha and the epidermal growth factor receptor. Med Oncol (2001) 0.78
Benign prostatic hyperplasia: diagnosis and treatment guideline. Ann Pharmacother (1997) 0.78
Cellular immunity in bladder cancer patients. J Urol (1978) 0.78
Screening tests for detection of bladder cancer. Urology (1980) 0.78
Spontaneous expulsion of an intravesical bullet. J Am Osteopath Assoc (1997) 0.78
Immunosuppressive effect of estrogen on thymic dependent lymphocytic blastogenesis. Urol Res (1974) 0.78
Combined use of Ovsynch and progesterone supplementation after artificial insemination in dairy cattle. J Dairy Sci (2012) 0.78
Methylene blue versus indigo carmine. Urology (1996) 0.78
To what extent are the "sets" of biologic properties expressed by hypoxic cancer cells and by cancer "stem" cells equivalent, intersecting, disjoint or complementary? Some implications for the design of cancer therapies. Med Hypotheses (2006) 0.77
Quality of life in metastatic prostate cancer among men of lower socioeconomic status: feasibility and criterion related validity of 3 measures. J Urol (1998) 0.77
Effects of maxillary advancement and impaction on nasal airway function. Int J Oral Maxillofac Surg (2012) 0.77
Urinary immunoglobulin A in the diagnosis of bladder cancer. J Surg Oncol (1981) 0.77
A comparison of Zoladex and DES in the treatment of advanced prostate cancer: results of a randomized, multicenter trial. Prostate (1991) 0.77
Antitumor effect of CPT-11, a new derivative of camptothecin, against human prostate cancer (PC-3) in vitro and prostate rat tumor (AT-3) in vivo. Methods Find Exp Clin Pharmacol (1996) 0.77